{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:33:40Z","timestamp":1764732820763,"version":"3.40.5"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijid.2019.07.039","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T17:00:37Z","timestamp":1565110837000},"page":"31-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["NK-cell post-transplant lymphoproliferative disease with chronic active Epstein\u2013Barr virus infection-like clinical findings"],"prefix":"10.1016","volume":"88","author":[{"given":"Tomoki","family":"Iemura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-6271","authenticated-orcid":false,"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2019.07.039_bib0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2169\/internalmedicine.51.6769","article-title":"Recurrence of chronic active Epstein\u2013Barr virus infection from donor cells after achieving complete response through allogeneic bone marrow transplantation","volume":"51","author":"Arai","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.ijid.2019.07.039_bib0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10875-015-0168-y","article-title":"Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1)","volume":"35","author":"Cohen","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijid.2019.07.039_bib0015","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","article-title":"A distinct subtype of Epstein\u2013Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein\u2013Barr virus infection-like features","volume":"103","author":"Kawamoto","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.ijid.2019.07.039_bib0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein\u2013Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2019.07.039_bib0025","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/605610","article-title":"Identification of Epstein\u2013Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases","volume":"200","author":"Kimura","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2019.07.039_bib0030","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK\u2013cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"year":"2019","series-title":"National Center for Biotechnology Information, ClinVar","key":"10.1016\/j.ijid.2019.07.039_bib0035"},{"key":"10.1016\/j.ijid.2019.07.039_bib0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosisng chronic active Epstein\u2013Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijid.2019.07.039_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein\u2013Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijid.2019.07.039_bib0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","article-title":"T-cell and NK-cell posttransplantation lymphoproliferative disorders","volume":"127","author":"Swerdlow","year":"2007","journal-title":"Am J Clin Pathol"},{"year":"2017","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition","author":"Swerdlow","key":"10.1016\/j.ijid.2019.07.039_bib0055"},{"key":"10.1016\/j.ijid.2019.07.039_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1272\/jnms.83.35","article-title":"Epstein\u2013Barr virus-positive T-cell lymphoproliferative disease following umbilical cord blood transplantation for acute myeloid leukemia","volume":"83","author":"Yui","year":"2016","journal-title":"J Nippon Med Sch"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121930325X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121930325X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T02:17:56Z","timestamp":1572747476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197121930325X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":12,"alternative-id":["S120197121930325X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.07.039","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK-cell post-transplant lymphoproliferative disease with chronic active Epstein\u2013Barr virus infection-like clinical findings","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}